ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Live and Attenuated Vaccine Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-6S14636
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Live and Attenuated Vaccine Market Research Report 2023
BUY CHAPTERS

Global Live and Attenuated Vaccine Market Research Report 2025

Code: QYRE-Auto-6S14636
Report
May 2025
Pages:82
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
GlaxoSmithKline PLC
Merck
Pfizer Inc
Astellas Pharma Inc
Johnson & Johnson
CSL Limited
MedImmune
Serum Institute
Emergent BioSolutions Inc
Sanofi

Live and Attenuated Vaccine Market

The global market for Live and Attenuated Vaccine was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Live and Attenuated Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Live and Attenuated Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Live and Attenuated Vaccine include GlaxoSmithKline, Merck & Co., Pfizer, Inc, Astellas Pharma Inc, Johnson & Johnson, CSL Limited, Emergent BioSolutions, Inc., MedImmune, LLC, Sanofi, Serum Institute, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Live and Attenuated Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Live and Attenuated Vaccine.
The Live and Attenuated Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Live and Attenuated Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Live and Attenuated Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Live and Attenuated Vaccine Market Report

Report Metric Details
Report Name Live and Attenuated Vaccine Market
Segment by Type
  • Pediatric Vaccine
  • Adult Vaccines
Segment by Application
  • Hospitals
  • Clinics
  • Diagnostic Centers
  • Research Institute
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company GlaxoSmithKline, Merck & Co., Pfizer, Inc, Astellas Pharma Inc, Johnson & Johnson, CSL Limited, Emergent BioSolutions, Inc., MedImmune, LLC, Sanofi, Serum Institute
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Live and Attenuated Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Live and Attenuated Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Live and Attenuated Vaccine Market report?

Ans: The main players in the Live and Attenuated Vaccine Market are GlaxoSmithKline, Merck & Co., Pfizer, Inc, Astellas Pharma Inc, Johnson & Johnson, CSL Limited, Emergent BioSolutions, Inc., MedImmune, LLC, Sanofi, Serum Institute

What are the Application segmentation covered in the Live and Attenuated Vaccine Market report?

Ans: The Applications covered in the Live and Attenuated Vaccine Market report are Hospitals, Clinics, Diagnostic Centers, Research Institute, Others

What are the Type segmentation covered in the Live and Attenuated Vaccine Market report?

Ans: The Types covered in the Live and Attenuated Vaccine Market report are Pediatric Vaccine, Adult Vaccines

1 Live and Attenuated Vaccine Market Overview
1.1 Product Definition
1.2 Live and Attenuated Vaccine by Type
1.2.1 Global Live and Attenuated Vaccine Market Value Comparison by Type (2024 VS 2031)
1.2.2 Pediatric Vaccine
1.2.3 Adult Vaccines
1.3 Live and Attenuated Vaccine by Application
1.3.1 Global Live and Attenuated Vaccine Market Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Diagnostic Centers
1.3.5 Research Institute
1.3.6 Others
1.4 Global Live and Attenuated Vaccine Market Size Estimates and Forecasts
1.4.1 Global Live and Attenuated Vaccine Revenue 2020-2031
1.4.2 Global Live and Attenuated Vaccine Sales 2020-2031
1.4.3 Global Live and Attenuated Vaccine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Live and Attenuated Vaccine Market Competition by Manufacturers
2.1 Global Live and Attenuated Vaccine Sales Market Share by Manufacturers (2020-2025)
2.2 Global Live and Attenuated Vaccine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Live and Attenuated Vaccine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Live and Attenuated Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Live and Attenuated Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Live and Attenuated Vaccine, Product Type & Application
2.7 Global Key Manufacturers of Live and Attenuated Vaccine, Date of Enter into This Industry
2.8 Global Live and Attenuated Vaccine Market Competitive Situation and Trends
2.8.1 Global Live and Attenuated Vaccine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Live and Attenuated Vaccine Players Market Share by Revenue
2.8.3 Global Live and Attenuated Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Live and Attenuated Vaccine Market Scenario by Region
3.1 Global Live and Attenuated Vaccine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Live and Attenuated Vaccine Sales by Region: 2020-2031
3.2.1 Global Live and Attenuated Vaccine Sales by Region: 2020-2025
3.2.2 Global Live and Attenuated Vaccine Sales by Region: 2026-2031
3.3 Global Live and Attenuated Vaccine Revenue by Region: 2020-2031
3.3.1 Global Live and Attenuated Vaccine Revenue by Region: 2020-2025
3.3.2 Global Live and Attenuated Vaccine Revenue by Region: 2026-2031
3.4 North America Live and Attenuated Vaccine Market Facts & Figures by Country
3.4.1 North America Live and Attenuated Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Live and Attenuated Vaccine Sales by Country (2020-2031)
3.4.3 North America Live and Attenuated Vaccine Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Live and Attenuated Vaccine Market Facts & Figures by Country
3.5.1 Europe Live and Attenuated Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Live and Attenuated Vaccine Sales by Country (2020-2031)
3.5.3 Europe Live and Attenuated Vaccine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Live and Attenuated Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Live and Attenuated Vaccine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Live and Attenuated Vaccine Sales by Region (2020-2031)
3.6.3 Asia Pacific Live and Attenuated Vaccine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Live and Attenuated Vaccine Market Facts & Figures by Country
3.7.1 Latin America Live and Attenuated Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Live and Attenuated Vaccine Sales by Country (2020-2031)
3.7.3 Latin America Live and Attenuated Vaccine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Live and Attenuated Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Live and Attenuated Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Live and Attenuated Vaccine Sales by Country (2020-2031)
3.8.3 Middle East and Africa Live and Attenuated Vaccine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Live and Attenuated Vaccine Sales by Type (2020-2031)
4.1.1 Global Live and Attenuated Vaccine Sales by Type (2020-2025)
4.1.2 Global Live and Attenuated Vaccine Sales by Type (2026-2031)
4.1.3 Global Live and Attenuated Vaccine Sales Market Share by Type (2020-2031)
4.2 Global Live and Attenuated Vaccine Revenue by Type (2020-2031)
4.2.1 Global Live and Attenuated Vaccine Revenue by Type (2020-2025)
4.2.2 Global Live and Attenuated Vaccine Revenue by Type (2026-2031)
4.2.3 Global Live and Attenuated Vaccine Revenue Market Share by Type (2020-2031)
4.3 Global Live and Attenuated Vaccine Price by Type (2020-2031)
5 Segment by Application
5.1 Global Live and Attenuated Vaccine Sales by Application (2020-2031)
5.1.1 Global Live and Attenuated Vaccine Sales by Application (2020-2025)
5.1.2 Global Live and Attenuated Vaccine Sales by Application (2026-2031)
5.1.3 Global Live and Attenuated Vaccine Sales Market Share by Application (2020-2031)
5.2 Global Live and Attenuated Vaccine Revenue by Application (2020-2031)
5.2.1 Global Live and Attenuated Vaccine Revenue by Application (2020-2025)
5.2.2 Global Live and Attenuated Vaccine Revenue by Application (2026-2031)
5.2.3 Global Live and Attenuated Vaccine Revenue Market Share by Application (2020-2031)
5.3 Global Live and Attenuated Vaccine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 GlaxoSmithKline
6.1.1 GlaxoSmithKline Company Information
6.1.2 GlaxoSmithKline Description and Business Overview
6.1.3 GlaxoSmithKline Live and Attenuated Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 GlaxoSmithKline Live and Attenuated Vaccine Product Portfolio
6.1.5 GlaxoSmithKline Recent Developments/Updates
6.2 Merck & Co.
6.2.1 Merck & Co. Company Information
6.2.2 Merck & Co. Description and Business Overview
6.2.3 Merck & Co. Live and Attenuated Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Merck & Co. Live and Attenuated Vaccine Product Portfolio
6.2.5 Merck & Co. Recent Developments/Updates
6.3 Pfizer, Inc
6.3.1 Pfizer, Inc Company Information
6.3.2 Pfizer, Inc Description and Business Overview
6.3.3 Pfizer, Inc Live and Attenuated Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Pfizer, Inc Live and Attenuated Vaccine Product Portfolio
6.3.5 Pfizer, Inc Recent Developments/Updates
6.4 Astellas Pharma Inc
6.4.1 Astellas Pharma Inc Company Information
6.4.2 Astellas Pharma Inc Description and Business Overview
6.4.3 Astellas Pharma Inc Live and Attenuated Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Astellas Pharma Inc Live and Attenuated Vaccine Product Portfolio
6.4.5 Astellas Pharma Inc Recent Developments/Updates
6.5 Johnson & Johnson
6.5.1 Johnson & Johnson Company Information
6.5.2 Johnson & Johnson Description and Business Overview
6.5.3 Johnson & Johnson Live and Attenuated Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Johnson & Johnson Live and Attenuated Vaccine Product Portfolio
6.5.5 Johnson & Johnson Recent Developments/Updates
6.6 CSL Limited
6.6.1 CSL Limited Company Information
6.6.2 CSL Limited Description and Business Overview
6.6.3 CSL Limited Live and Attenuated Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.6.4 CSL Limited Live and Attenuated Vaccine Product Portfolio
6.6.5 CSL Limited Recent Developments/Updates
6.7 Emergent BioSolutions, Inc.
6.7.1 Emergent BioSolutions, Inc. Company Information
6.7.2 Emergent BioSolutions, Inc. Description and Business Overview
6.7.3 Emergent BioSolutions, Inc. Live and Attenuated Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Emergent BioSolutions, Inc. Live and Attenuated Vaccine Product Portfolio
6.7.5 Emergent BioSolutions, Inc. Recent Developments/Updates
6.8 MedImmune, LLC
6.8.1 MedImmune, LLC Company Information
6.8.2 MedImmune, LLC Description and Business Overview
6.8.3 MedImmune, LLC Live and Attenuated Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.8.4 MedImmune, LLC Live and Attenuated Vaccine Product Portfolio
6.8.5 MedImmune, LLC Recent Developments/Updates
6.9 Sanofi
6.9.1 Sanofi Company Information
6.9.2 Sanofi Description and Business Overview
6.9.3 Sanofi Live and Attenuated Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Sanofi Live and Attenuated Vaccine Product Portfolio
6.9.5 Sanofi Recent Developments/Updates
6.10 Serum Institute
6.10.1 Serum Institute Company Information
6.10.2 Serum Institute Description and Business Overview
6.10.3 Serum Institute Live and Attenuated Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Serum Institute Live and Attenuated Vaccine Product Portfolio
6.10.5 Serum Institute Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Live and Attenuated Vaccine Industry Chain Analysis
7.2 Live and Attenuated Vaccine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Live and Attenuated Vaccine Production Mode & Process Analysis
7.4 Live and Attenuated Vaccine Sales and Marketing
7.4.1 Live and Attenuated Vaccine Sales Channels
7.4.2 Live and Attenuated Vaccine Distributors
7.5 Live and Attenuated Vaccine Customer Analysis
8 Live and Attenuated Vaccine Market Dynamics
8.1 Live and Attenuated Vaccine Industry Trends
8.2 Live and Attenuated Vaccine Market Drivers
8.3 Live and Attenuated Vaccine Market Challenges
8.4 Live and Attenuated Vaccine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
GlaxoSmithKline PLC
Merck
Pfizer Inc
Astellas Pharma Inc
Johnson & Johnson
CSL Limited
MedImmune
Serum Institute
Emergent BioSolutions Inc
Sanofi
List of Tables
 Table 1. Global Live and Attenuated Vaccine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Live and Attenuated Vaccine Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Live and Attenuated Vaccine Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Live and Attenuated Vaccine Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Live and Attenuated Vaccine Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Live and Attenuated Vaccine Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Live and Attenuated Vaccine Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Live and Attenuated Vaccine Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Live and Attenuated Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Live and Attenuated Vaccine, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Live and Attenuated Vaccine, Product Type & Application
 Table 12. Global Key Manufacturers of Live and Attenuated Vaccine, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Live and Attenuated Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Live and Attenuated Vaccine as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Live and Attenuated Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Live and Attenuated Vaccine Sales by Region (2020-2025) & (K Units)
 Table 18. Global Live and Attenuated Vaccine Sales Market Share by Region (2020-2025)
 Table 19. Global Live and Attenuated Vaccine Sales by Region (2026-2031) & (K Units)
 Table 20. Global Live and Attenuated Vaccine Sales Market Share by Region (2026-2031)
 Table 21. Global Live and Attenuated Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Live and Attenuated Vaccine Revenue Market Share by Region (2020-2025)
 Table 23. Global Live and Attenuated Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Live and Attenuated Vaccine Revenue Market Share by Region (2026-2031)
 Table 25. North America Live and Attenuated Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Live and Attenuated Vaccine Sales by Country (2020-2025) & (K Units)
 Table 27. North America Live and Attenuated Vaccine Sales by Country (2026-2031) & (K Units)
 Table 28. North America Live and Attenuated Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Live and Attenuated Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Live and Attenuated Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Live and Attenuated Vaccine Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Live and Attenuated Vaccine Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Live and Attenuated Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Live and Attenuated Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Live and Attenuated Vaccine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Live and Attenuated Vaccine Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Live and Attenuated Vaccine Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Live and Attenuated Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Live and Attenuated Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Live and Attenuated Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Live and Attenuated Vaccine Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Live and Attenuated Vaccine Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Live and Attenuated Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Live and Attenuated Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Live and Attenuated Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Live and Attenuated Vaccine Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Live and Attenuated Vaccine Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Live and Attenuated Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Live and Attenuated Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Live and Attenuated Vaccine Sales (K Units) by Type (2020-2025)
 Table 51. Global Live and Attenuated Vaccine Sales (K Units) by Type (2026-2031)
 Table 52. Global Live and Attenuated Vaccine Sales Market Share by Type (2020-2025)
 Table 53. Global Live and Attenuated Vaccine Sales Market Share by Type (2026-2031)
 Table 54. Global Live and Attenuated Vaccine Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Live and Attenuated Vaccine Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Live and Attenuated Vaccine Revenue Market Share by Type (2020-2025)
 Table 57. Global Live and Attenuated Vaccine Revenue Market Share by Type (2026-2031)
 Table 58. Global Live and Attenuated Vaccine Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Live and Attenuated Vaccine Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Live and Attenuated Vaccine Sales (K Units) by Application (2020-2025)
 Table 61. Global Live and Attenuated Vaccine Sales (K Units) by Application (2026-2031)
 Table 62. Global Live and Attenuated Vaccine Sales Market Share by Application (2020-2025)
 Table 63. Global Live and Attenuated Vaccine Sales Market Share by Application (2026-2031)
 Table 64. Global Live and Attenuated Vaccine Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Live and Attenuated Vaccine Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Live and Attenuated Vaccine Revenue Market Share by Application (2020-2025)
 Table 67. Global Live and Attenuated Vaccine Revenue Market Share by Application (2026-2031)
 Table 68. Global Live and Attenuated Vaccine Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Live and Attenuated Vaccine Price (US$/Unit) by Application (2026-2031)
 Table 70. GlaxoSmithKline Company Information
 Table 71. GlaxoSmithKline Description and Business Overview
 Table 72. GlaxoSmithKline Live and Attenuated Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. GlaxoSmithKline Live and Attenuated Vaccine Product
 Table 74. GlaxoSmithKline Recent Developments/Updates
 Table 75. Merck & Co. Company Information
 Table 76. Merck & Co. Description and Business Overview
 Table 77. Merck & Co. Live and Attenuated Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Merck & Co. Live and Attenuated Vaccine Product
 Table 79. Merck & Co. Recent Developments/Updates
 Table 80. Pfizer, Inc Company Information
 Table 81. Pfizer, Inc Description and Business Overview
 Table 82. Pfizer, Inc Live and Attenuated Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Pfizer, Inc Live and Attenuated Vaccine Product
 Table 84. Pfizer, Inc Recent Developments/Updates
 Table 85. Astellas Pharma Inc Company Information
 Table 86. Astellas Pharma Inc Description and Business Overview
 Table 87. Astellas Pharma Inc Live and Attenuated Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Astellas Pharma Inc Live and Attenuated Vaccine Product
 Table 89. Astellas Pharma Inc Recent Developments/Updates
 Table 90. Johnson & Johnson Company Information
 Table 91. Johnson & Johnson Description and Business Overview
 Table 92. Johnson & Johnson Live and Attenuated Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Johnson & Johnson Live and Attenuated Vaccine Product
 Table 94. Johnson & Johnson Recent Developments/Updates
 Table 95. CSL Limited Company Information
 Table 96. CSL Limited Description and Business Overview
 Table 97. CSL Limited Live and Attenuated Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. CSL Limited Live and Attenuated Vaccine Product
 Table 99. CSL Limited Recent Developments/Updates
 Table 100. Emergent BioSolutions, Inc. Company Information
 Table 101. Emergent BioSolutions, Inc. Description and Business Overview
 Table 102. Emergent BioSolutions, Inc. Live and Attenuated Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Emergent BioSolutions, Inc. Live and Attenuated Vaccine Product
 Table 104. Emergent BioSolutions, Inc. Recent Developments/Updates
 Table 105. MedImmune, LLC Company Information
 Table 106. MedImmune, LLC Description and Business Overview
 Table 107. MedImmune, LLC Live and Attenuated Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. MedImmune, LLC Live and Attenuated Vaccine Product
 Table 109. MedImmune, LLC Recent Developments/Updates
 Table 110. Sanofi Company Information
 Table 111. Sanofi Description and Business Overview
 Table 112. Sanofi Live and Attenuated Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Sanofi Live and Attenuated Vaccine Product
 Table 114. Sanofi Recent Developments/Updates
 Table 115. Serum Institute Company Information
 Table 116. Serum Institute Description and Business Overview
 Table 117. Serum Institute Live and Attenuated Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Serum Institute Live and Attenuated Vaccine Product
 Table 119. Serum Institute Recent Developments/Updates
 Table 120. Key Raw Materials Lists
 Table 121. Raw Materials Key Suppliers Lists
 Table 122. Live and Attenuated Vaccine Distributors List
 Table 123. Live and Attenuated Vaccine Customers List
 Table 124. Live and Attenuated Vaccine Market Trends
 Table 125. Live and Attenuated Vaccine Market Drivers
 Table 126. Live and Attenuated Vaccine Market Challenges
 Table 127. Live and Attenuated Vaccine Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Live and Attenuated Vaccine
 Figure 2. Global Live and Attenuated Vaccine Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Live and Attenuated Vaccine Market Share by Type: 2024 & 2031
 Figure 4. Pediatric Vaccine Product Picture
 Figure 5. Adult Vaccines Product Picture
 Figure 6. Global Live and Attenuated Vaccine Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Live and Attenuated Vaccine Market Share by Application: 2024 & 2031
 Figure 8. Hospitals
 Figure 9. Clinics
 Figure 10. Diagnostic Centers
 Figure 11. Research Institute
 Figure 12. Others
 Figure 13. Global Live and Attenuated Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Live and Attenuated Vaccine Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Live and Attenuated Vaccine Sales (2020-2031) & (K Units)
 Figure 16. Global Live and Attenuated Vaccine Average Price (US$/Unit) & (2020-2031)
 Figure 17. Live and Attenuated Vaccine Report Years Considered
 Figure 18. Live and Attenuated Vaccine Sales Share by Manufacturers in 2024
 Figure 19. Global Live and Attenuated Vaccine Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest Live and Attenuated Vaccine Players: Market Share by Revenue in Live and Attenuated Vaccine in 2024
 Figure 21. Live and Attenuated Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global Live and Attenuated Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America Live and Attenuated Vaccine Sales Market Share by Country (2020-2031)
 Figure 24. North America Live and Attenuated Vaccine Revenue Market Share by Country (2020-2031)
 Figure 25. United States Live and Attenuated Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada Live and Attenuated Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe Live and Attenuated Vaccine Sales Market Share by Country (2020-2031)
 Figure 28. Europe Live and Attenuated Vaccine Revenue Market Share by Country (2020-2031)
 Figure 29. Germany Live and Attenuated Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France Live and Attenuated Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. Live and Attenuated Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy Live and Attenuated Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia Live and Attenuated Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific Live and Attenuated Vaccine Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific Live and Attenuated Vaccine Revenue Market Share by Region (2020-2031)
 Figure 36. China Live and Attenuated Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan Live and Attenuated Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea Live and Attenuated Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India Live and Attenuated Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia Live and Attenuated Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. China Taiwan Live and Attenuated Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Southeast Asia Live and Attenuated Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Live and Attenuated Vaccine Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Live and Attenuated Vaccine Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Live and Attenuated Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Live and Attenuated Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Live and Attenuated Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Live and Attenuated Vaccine Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Live and Attenuated Vaccine Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Live and Attenuated Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Live and Attenuated Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. UAE Live and Attenuated Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Live and Attenuated Vaccine by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Live and Attenuated Vaccine by Type (2020-2031)
 Figure 55. Global Live and Attenuated Vaccine Price (US$/Unit) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Live and Attenuated Vaccine by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Live and Attenuated Vaccine by Application (2020-2031)
 Figure 58. Global Live and Attenuated Vaccine Price (US$/Unit) by Application (2020-2031)
 Figure 59. Live and Attenuated Vaccine Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

Global Live Vaccines Market Research Report 2024
Global Live Attenuated Polio Vaccine Market Research Report 2024
Global Live Attenuated Vaccines for Pets Market Research Report 2025
Live Attenuated Japanese Encephalitis Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Live Attenuated Measles Vaccine Market Research Report 2025
VLP Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Measles Combined with Live Attenuated Vaccine Market Research Report 2025
Commercial Fish Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Vaccine Container Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Animal Flu Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Aquatic Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Adult Vaccines Market Research Report 2024
Live Attenuated Herpes Zoster Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Vaccines for the Elderly Market Research Report 2024
Global Live Attenuated Vaccine for Chickenpox Market Research Report 2025
Global Attenuated Vaccine Market Research Report 2025
Gene Deletion Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Multiple Vaccine Market Research Report 2024
Global Consumption Type Vaccine Market Research Report 2024
Global Adult and Pediatric Vaccines Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions